姑息放疗后骨转移疼痛净缓解时间:反映疗效持续时间的有用指标?
本研究为荷兰骨转移研究的事后分析,比较单次8 Gy与24 Gy/6次姑息放疗后疼痛净缓解(NPR)比例。疼痛改善患者余生的56.6%处于缓解期;NPR可用于评估疼痛缓解持久性,但需注意缺失数据与再放疗方案的影响。
要点
- 疼痛改善患者余生约56.6%时间处于疼痛缓解状态。
核心结论
- 对传统放疗有效的患者,其剩余生命约一半时间疼痛控制得到改善。
- NPR可能为评估疼痛缓解持久性提供有价值的信息。
- 缺失数据不可避免,须最小化并认识及报告其后果。
- 再放疗方案及试验随访频率和时长可能显著影响NPR,未来研究设计需谨慎考虑。
研究设计与样本
- 荷兰骨转移研究的事后分析,随机对照试验比较单次8 Gy与24 Gy/6次姑息放疗。
- 按生存队列、治疗方案和原发诊断评估NPR,并用敏感性分析考虑缺失数据的影响。
主要发现
- 疼痛改善患者余生的56.6%处于疼痛缓解期。
- 问卷缺失应答使NPR的不确定范围为36.1%至62.1%。
- 再放疗意愿差异可能影响NPR结果。
关键数值与推荐
- NPR定义为剩余生命中处于疼痛缓解的比例。
临床怎么用
- NPR可作为评估骨转移姑息放疗疼痛缓解持久性的补充指标。
- 临床解读NPR时需考虑再放疗方案及随访安排的影响。
- 应尽量减少随访问卷缺失数据并报告其潜在影响。
局限性
- 为事后再分析,非预设主要终点。
- 问卷缺失应答导致NPR不确定范围较宽(36.1%至62.1%)。
- 再放疗意愿差异可能混杂NPR比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Pain response rates are equivalent after single 8 Gy and fractionated palliative radiation therapy for bone metastases. Reirradiation remains more frequent after a single fraction, although this does not simply reflect pain recurrence. Given the possible role of stereotactic radiation therapy in providing durable pain control, measures of durability are required. Net pain relief (NPR), the proportion of remaining life spent with pain response, may provide this. This study assesses the use of NPR as an outcome measure after palliative radiation therapy for bone metastases. METHODS AND MATERIALS: This is a secondary analysis of data collected in the Dutch Bone Metastasis Study, a randomized trial comparing palliative radiation therapy delivered as 8 Gy in a single fraction and 24 Gy in 6 fractions. NPR was assessed by survival cohorts, treatment regimen, and primary diagnoses. The consequences of missing data upon the use of NPR in future studies were considered within sensitivity analyses. RESULTS: Patients whose pain improved after palliative radiation therapy experienced improvement for 56.6% of their remaining lives. Missing responses in questionnaires mean the range of uncertainty in NPR is 36.1% to 62.1%. When response beyond reirradiation was excluded, NPR after treatments of single-fraction 8 Gy and 24 Gy in 6 fractions was 49.0% and 56.5%, respectively (P = .004). Differential willingness to reirradiate may be influencing this outcome. When response beyond reirradiation was included, this difference was not seen (NPR of 55.4% vs 57.7%, respectively [P = .191]). CONCLUSIONS: Patients who responded to conventional radiation therapy experienced improved pain control for approximately half of their remaining life. NPR may provide valuable information in assessing pain response durability. Missing data are, however, inevitable in this population. This must be minimized and the consequences recognized and reported. Additionally, reirradiation protocols and the frequency and duration of trial follow-up may have a significant impact upon this outcome, requiring careful consideration during trial design if NPR is to be used in future studies.
引用
- Spencer K, Velikova G, Henry A, et al. Net Pain Relief After Palliative Radiation Therapy for Painful Bone Metastases: A Useful Measure to Reflect Response Duration? A Further Analysis of the Dutch Bone Metastasis Study. Int J Radiat Oncol Biol Phys. 2019. PMID: 31344434. doi:10.1016/j.ijrobp.2019.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。